Seres Therapeutics, Inc. (MCRB)
2.09
-0.04
(-1.88%)
USD |
NASDAQ |
Oct 23, 16:00
2.10
+0.01
(+0.48%)
After-Hours: 20:00
Seres Therapeutics Price : 2.09 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 2.13 | 2.17 | 2.00 | 2.09 | 69713.00 |
| Oct 22, 2026 | 2.29 | 2.30 | 2.02 | 2.13 | 132204.0 |
| Oct 21, 2026 | 2.30 | 2.40 | 2.261 | 2.30 | 41768.00 |
| Oct 20, 2026 | 2.41 | 2.550 | 2.31 | 2.31 | 66981.00 |
| Oct 19, 2026 | 2.46 | 2.58 | 2.415 | 2.42 | 23366.00 |
| Oct 16, 2026 | 2.56 | 2.56 | 2.422 | 2.46 | 38569.00 |
| Oct 15, 2026 | 2.40 | 2.610 | 2.40 | 2.53 | 24614.00 |
| Oct 14, 2026 | 2.65 | 2.66 | 2.385 | 2.42 | 42972.00 |
| Oct 13, 2026 | 2.66 | 2.66 | 2.51 | 2.53 | 44061.00 |
| Oct 12, 2026 | 2.75 | 2.78 | 2.66 | 2.68 | 54279.00 |
| Oct 09, 2026 | 2.65 | 2.75 | 2.58 | 2.71 | 79411.00 |
| Oct 08, 2026 | 2.68 | 2.724 | 2.42 | 2.63 | 213361.0 |
| Oct 07, 2026 | 2.86 | 3.00 | 2.70 | 2.72 | 60382.00 |
| Oct 06, 2026 | 2.875 | 3.020 | 2.80 | 2.90 | 76422.00 |
| Oct 05, 2026 | 2.91 | 2.91 | 2.81 | 2.85 | 63303.00 |
| Oct 02, 2026 | 2.98 | 3.20 | 2.91 | 2.94 | 100954.0 |
| Oct 01, 2026 | 3.10 | 3.41 | 2.83 | 2.93 | 247329.0 |
| Sep 30, 2026 | 3.473 | 3.486 | 3.26 | 3.35 | 54614.00 |
| Sep 29, 2026 | 3.54 | 3.585 | 3.35 | 3.48 | 71289.00 |
| Sep 28, 2026 | 3.49 | 3.55 | 3.405 | 3.52 | 55486.00 |
| Sep 25, 2026 | 3.66 | 3.695 | 3.50 | 3.52 | 55674.00 |
| Sep 24, 2026 | 3.71 | 3.85 | 3.52 | 3.62 | 89565.00 |
| Sep 23, 2026 | 4.06 | 4.220 | 3.73 | 3.79 | 51648.00 |
| Sep 22, 2026 | 4.13 | 4.15 | 3.93 | 4.02 | 35743.00 |
| Sep 21, 2026 | 4.23 | 4.330 | 3.90 | 4.07 | 38808.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agenus, Inc. | 6.33 |
| Amgen, Inc. | 439.26 |
| Anika Therapeutics, Inc. | 21.42 |
| BioCryst Pharmaceuticals, Inc. | 7.65 |
| Imunon, Inc. | 1.235 |
Price Related Metrics
| PS Ratio | 10.45 |
| PEG Ratio | -0.0041 |
| Price to Book Value | 0.5948 |
| Earnings Yield | -109.0% |
| Market Cap | 20.54M |
| PEGY Ratio | -0.0041 |